VitaNova Life Sciences (VNOV) Net Income towards Common Stockholders Growth (3y) (2020 - 2026)
Powered by 
Analysis
VitaNova Life Sciences (VNOV) Net Income towards Common Stockholders Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 120.96 Bn | 111.91 Bn | 6.13 Bn | 5.25% |
| 2 | UL Solutions | 12.94 Bn | 12.53 Bn | 417.00 Mn | 36.90% |
| 3 | Gartner | 11.74 Bn | 10.25 Bn | 1.19 Bn | 11.63% |
| 4 | Booz Allen Hamilton Holding | 9.28 Bn | 8.74 Bn | 1.46 Bn | 7.05% |
| 5 | Tetra Tech | 9.14 Bn | 8.91 Bn | 243.21 Mn | 22.08% |
| 6 | Genpact | 5.74 Bn | 5.22 Bn | 490.34 Mn | 7.83% |
| 7 | Grand Canyon Education | 3.97 Bn | 3.69 Bn | 204.08 Mn | 16.53% |
| 8 | Fti Consulting | 3.91 Bn | 3.74 Bn | 316.27 Mn | -2.51% |
| 9 | Korn Ferry | 3.90 Bn | 3.09 Bn | 681.29 Mn | 13.78% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.90 Mn | 30,521.00 | -58.48% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 81.73% |
| Jan 31, 2026 | -21.76% |
| Oct 31, 2025 | 139.67% |
| Jul 31, 2025 | -187.23% |
| Apr 30, 2025 | 217.00% |
| Jan 31, 2025 | 101.52% |
| Oct 31, 2024 | 29.57% |
| Jul 31, 2024 | -33.65% |
| Apr 30, 2024 | 117.68% |
| Jan 31, 2024 | 59.42% |
| Oct 31, 2023 | 10.92% |
| Jul 31, 2023 | -37.88% |
| Apr 30, 2023 | 44.99% |
| Jan 31, 2023 | -55.05% |
| Oct 31, 2022 | 28.73% |
| Jul 31, 2022 | -36.74% |
| Apr 30, 2022 | -35.64% |
| Jan 31, 2022 | 30.90% |
| Oct 31, 2021 | 33.42% |
| Jul 31, 2021 | 148.65% |